{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:29:56Z","timestamp":1787506196000,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic>Background\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Monocyte chemoattractant proteins (MCPs) play an important role in mediating inflammatory processes. Hypertension (HTN) is associated with inflammation as well as impaired cardiac microcirculatory function and structure, but the contribution of MCPs to these alterations remained unclear. This study tested the hypothesis that MCPs regulate cardiac microvascular function and structure in experimental HTN.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Methods and Results\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Pigs (n=6 per group) were studied after 10 weeks of normal, renovascular HTN, or renovascular HTN+ bindarit (MCPs inhibitor, 50 mg\/kg\/d PO). Left ventricular (LV) function, myocardial microvascular permeability, and fractional vascular volume were assessed by fast computed tomography before and after adenosine infusion (400 \u03bcg\/kg\/min). Myocardial fibrosis, inflammation, and microvascular remodeling were determined ex vivo. Hypertension was not altered by bindarit, but LV hypertrophy and diastolic function were improved. In response to adenosine, myocardial microvascular permeability increased in HTN (from 0.0083\u00b10.0009 to 0.0103\u00b10.0011 AU,\n                    <jats:italic>P<\/jats:italic>\n                    =0.038 versus baseline) and fractional vascular volume decreased, whereas both remained unchanged in normal and HTN+bindarit pigs. HTN upregulated endothelin-1 expression, myocardial inflammation, and microvascular wall thickening, which were inhibited by bindarit.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Conclusions\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    MCPs partly mediate myocardial inflammation, fibrosis, vascular remodeling, and impaired vascular integrity induced by hypertension. Inhibition of MCPs could potentially be a therapeutic target in hypertensive cardiomyopathy.\n                  <\/jats:p>","DOI":"10.1161\/atvbaha.109.190546","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T22:05:35Z","timestamp":1248386735000},"page":"1810-1816","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Monocyte Chemoattractant Proteins Mediate Myocardial Microvascular Dysfunction in Swine Renovascular Hypertension"],"prefix":"10.1161","volume":"29","author":[{"given":"Jing","family":"Lin","sequence":"first","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zhu","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro R.","family":"Chade","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra L.","family":"Jordan","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Lavi","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Daghini","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Gibson","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Guglielmotti","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach O.","family":"Lerman","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology and Hypertension (J.L., X.Z., A.R.C., K.L.J., R.L., E.D., M.E.G., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, Minn; and the Angelini Research Center (A.G.), ACRAF, S. Palomba-Pomezia, Rome, Italy. Current affiliation for A.R.C.: the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson. Current affiliation for R.L.: the Department of Anesthesia and Perioperative Medicine, London Health Care Science..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.107.098640"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000111834.03000.e4"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra061889"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00538.2005"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00259.2005"},{"key":"e_1_3_3_6_2","first-page":"510","volume":"121","year":"1993","unstructured":"Reddy HK, Campbell SE, Janicki JS, Zhou G, Weber KT. Coronary microvascular fluid flux and permeability: influence of angiotensin II, aldosterone, and acute arterial hypertension. J Lab Clin Med. 1993; 121: 510\u2013521.","journal-title":"J Lab Clin Med"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.rli.0000258086.78179.90"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.102.19.2411"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.30.6.1397"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00424.x"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(00)90084-8"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01990-3"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.10.028"},{"key":"e_1_3_3_14_2","first-page":"437","volume":"10","year":"1999","unstructured":"Sironi M, Guglielmotti A, Polentarutti N, Fioretti F, Milanese C, Romano M, Vigini C, Coletta I, Sozzani S, Bernasconi S, Vecchi A, Pinza M, Mantovani A. A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur Cytokine Netw. 1999; 10: 437\u2013442.","journal-title":"Eur Cytokine Netw"},{"key":"e_1_3_3_15_2","first-page":"149","volume":"16","year":"1998","unstructured":"Guglielmotti A, Aquilini L, D'Onofrio E, Rosignoli MT, Milanese C, Pinza M. Bindarit prolongs survival and reduces renal damage in NZB\/W lupus mice. Clin Exp Rheumatol. 1998; 16: 149\u2013154.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00804.x"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.37.2.541"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1071455"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004080674"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.107.152959"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000125742.65841.8b"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.102.17.2028"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.0000194097.92824.b3"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.107.152322"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.0000227469.40826.01"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-999-0079-5"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000234111.31239.c3"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006090976"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(03)00250-5"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000118584.33350.7d"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000111831.50834.93"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318064f150"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000126924.23467.a3"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21975"},{"key":"e_1_3_3_35_2","first-page":"119","volume":"19","year":"2008","unstructured":"Mirolo M, Fabbri M, Sironi M, Vecchi A, Guglielmotti A, Mangano G, Biondi G, Locati M, Mantovani A. Impact of the anti-inflammatory agent bindarit on the chemokinome: selective inhibition of the monocyte chemotactic proteins. Eur Cytokine Netw. 2008; 19: 119\u2013122.","journal-title":"Eur Cytokine Netw"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2003.07.001"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00755"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1992.262.5.C1119"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.11.010"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01139-6"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00518.x"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119354"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(98)70212-5"}],"updated-by":[{"DOI":"10.1161\/atv.0b013e318203abc2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000}}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/ATVBAHA.109.190546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T19:04:28Z","timestamp":1715540668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/ATVBAHA.109.190546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1161\/ATVBAHA.109.190546"],"URL":"https:\/\/doi.org\/10.1161\/atvbaha.109.190546","relation":{},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"2009-07-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}